These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 25359532)

  • 21. A study of different methods for the assay of lipoprotein lipase activity in human adipose tissue.
    Persson B; Smith U; Larsson B
    Atherosclerosis; 1975; 22(3):425-30. PubMed ID: 1201144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specificity of lipoprotein lipase and hepatic lipase toward monoacylglycerols varying in the acyl composition.
    Miller CH; Parce JW; Sisson P; Waite M
    Biochim Biophys Acta; 1981 Sep; 665(3):385-92. PubMed ID: 7295742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetics of 2-monoacylglycerol acyl migration in model chylomicra.
    Lyubachevskaya G; Boyle-Roden E
    Lipids; 2000 Dec; 35(12):1353-8. PubMed ID: 11201997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positional specificity of triglyceride lipases in post-heparin plasma.
    Assmann G; Krauss RM; Fredrickson DS; Levy RI
    J Biol Chem; 1973 Oct; 248(20):7184-90. PubMed ID: 4743519
    [No Abstract]   [Full Text] [Related]  

  • 25. Metabolism of sn-1(3)-Monoacylglycerol and sn-2-Monoacylglycerol in Caecal Enterocytes and Hepatocytes of Brown Trout (Salmo trutta).
    Li K; Olsen RE
    Lipids; 2017 Jan; 52(1):61-71. PubMed ID: 27873162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolution of the diacylglycerol lipases.
    Yuan D; Wu Z; Wang Y
    Prog Lipid Res; 2016 Oct; 64():85-97. PubMed ID: 27568643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensing of triacylglycerol in the gut: different mechanisms for fatty acids and 2-monoacylglycerol.
    Kleberg K; Jacobsen AK; Ferreira JG; Windeløv JA; Rehfeld JF; Holst JJ; de Araujo IE; Hansen HS
    J Physiol; 2015 Apr; 593(8):2097-109. PubMed ID: 25639597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The participation of ethyl 4-benzyloxybenzoate (BRL 10894) and other aryl-substituted acids in glycerolipid metabolism.
    Fears R; Baggaley KH; Alexander R; Morgan B; Hindley RM
    J Lipid Res; 1978 Jan; 19(1):3-11. PubMed ID: 621438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assays for lipoprotein lipase: comparison of radiolabeled vs titration method and of triolein vs intralipid substrate.
    Whayne TF; Morelli JF
    Biochem Med; 1977 Jun; 17(3):248-57. PubMed ID: 869936
    [No Abstract]   [Full Text] [Related]  

  • 30. The synthesis of(14)C- and (3)H-labeled glycerol ethers.
    Oswald EO; Piantadosi C; Anderson CE; Snyder F
    Lipids; 1966 Jul; 1(4):241-6. PubMed ID: 17805623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ether in fatty tissue during ether absorption and elimination.
    DYBING O; SKOVLUND K
    Acta Pharmacol Toxicol (Copenh); 1957; 13(3):252-5. PubMed ID: 13434944
    [No Abstract]   [Full Text] [Related]  

  • 32. A categorical structure-activity relationship analysis of GPR119 ligands.
    Kumar P; Carrasquer CA; Carter A; Song ZH; Cunningham AR
    SAR QSAR Environ Res; 2014; 25(11):891-903. PubMed ID: 25401513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HD047703, a New Promising Anti-Diabetic Drug Candidate: In Vivo Preclinical Studies.
    Kim S; Kim DH; Kim YS; Ha TY; Yang J; Park SH; Jeong KW; Rhee JK
    Biomol Ther (Seoul); 2014 Sep; 22(5):400-5. PubMed ID: 25414769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct activation of the proposed anti-diabetic receptor, GPR119 in cardiomyoblasts decreases markers of muscle metabolic activity.
    Cornall LM; Hryciw DH; Mathai ML; McAinch AJ
    Mol Cell Endocrinol; 2015 Feb; 402():72-85. PubMed ID: 25578601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipolysis, and not hepatic lipogenesis, is the primary modulator of triglyceride levels in streptozotocin-induced diabetic mice.
    Willecke F; Scerbo D; Nagareddy P; Obunike JC; Barrett TJ; Abdillahi ML; Trent CM; Huggins LA; Fisher EA; Drosatos K; Goldberg IJ
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):102-10. PubMed ID: 25395613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel apolipoprotein C-II mimetic peptide that activates lipoprotein lipase and decreases serum triglycerides in apolipoprotein E-knockout mice.
    Amar MJ; Sakurai T; Sakurai-Ikuta A; Sviridov D; Freeman L; Ahsan L; Remaley AT
    J Pharmacol Exp Ther; 2015 Feb; 352(2):227-35. PubMed ID: 25395590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel tricyclic pyrazolopyrimidines as potent and selective GPR119 agonists.
    Azimioara M; Alper P; Cow C; Mutnick D; Nikulin V; Lelais G; Mecom J; McNeill M; Michellys PY; Wang Z; Reding E; Paliotti M; Li J; Bao D; Zoll J; Kim Y; Zimmerman M; Groessl T; Tuntland T; Joseph SB; McNamara P; Seidel HM; Epple R
    Bioorg Med Chem Lett; 2014 Dec; 24(23):5478-83. PubMed ID: 25455488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrinsic and extrinsic regulation of cardiac lipoprotein lipase following diabetes.
    Wang Y; Rodrigues B
    Biochim Biophys Acta; 2015 Feb; 1851(2):163-71. PubMed ID: 25463481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoprotein lipase: from gene to atherosclerosis.
    Li Y; He PP; Zhang DW; Zheng XL; Cayabyab FS; Yin WD; Tang CK
    Atherosclerosis; 2014 Dec; 237(2):597-608. PubMed ID: 25463094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GPIHBP1 missense mutations often cause multimerization of GPIHBP1 and thereby prevent lipoprotein lipase binding.
    Beigneux AP; Fong LG; Bensadoun A; Davies BS; Oberer M; Gårdsvoll H; Ploug M; Young SG
    Circ Res; 2015 Feb; 116(4):624-32. PubMed ID: 25387803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.